Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a ß3-adrenoceptor agonist (Mirabegron) for overactive bladder (OAB). (2015)

First Author: Rossanese M
Attributed to:  MRC Centre for Transplantation funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 24602031

Publication URI:

Type: Journal Article/Review

Volume: 115

Parent Publication: BJU international

Issue: 1

ISSN: 1464-4096